Software from VLife Sciences Helping to Research Drug Discovery & Toxicology
3 Oct 2010VLife Sciences Technologies Pvt. Ltd. announces that The Agency for Toxic Substances and Disease Registry (ATSDR), at Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA will use its flagship software product VLifeMDSTM 3.5 for conducting cutting edge research in drug discovery and toxicologystudies. This includes its patented technology GQSAR and hybrid lead optimization approach VLife SCOPE (Structure Based Compound Optimization Prioritization and Evolution).
‘We are very pleased to be associated with one of the finest center of disease control in the world. We are confident that with this advanced software the research community at ATSDR, Atlanta, USA will be able to expedite their research projects and further improve their R & D productivity’, said VLife’s CEO Mr. Supreet Deshpande.
Related Products
Request Quote for All Products
VLifeMDS Molecular Design Suite
VLife Sciences Technologies Pvt. Ltd.VLifeMDS (Molecular Design Suite), is a computational chemist’s workbench for computer aided drug design (CADD) and molecule discovery. MDS comes with seamless integration to GQSAR, (Group based QSAR) and SCOPE. VLifeMDS facilitates comprehensive in-silico approach to design. It is able to visualize, predict and analyze small molecules and proteins while studying interactions. VLifeMDS extensively deals with:• Protein structure analysis • Active site analysis • Homology modeling • Pharmacophore identification • Conformer generation • Combinatorial library • Property visualization • Docking • QSAR analysis • Database querying • Virtual screening